ACE2 and COVID-19: Indeed, ACE2 expression in the lungs correlates with severe COVID-19 (Pinto et al., 2020), and human recombinant soluble ACE2 (hrsACE2) may block SARS-CoV-2 infection (Monteil et al., 2020; Monteil et al., 2022).